Robert Call
Allergy · Richmond, VANPI 1063521904
Payments from drug & device makers
Across 2,346 payments — averaging $15,251 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$25M
- Kaleo, Inc.$1.9M
- Incyte Corporation$1.9M
- Merck$1.7M
- Astrazeneca UK Limited$1.5M
- Sanofi US Services Inc.$919K
- plus $2.9M from 41 others
Across 165 payments — averaging $1944.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Glenmark Pharmaceuticals Inc., USA$207K
- Ichnos Glenmark Innovation Inc$113K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$35,779,455 in reported general payments places this provider in the 95th percentile of 26 allergy providers in Virginia.
Other allergy in Richmond
- Lawrence GelberRichmond$1.9M
- William HarkRichmond$945K
- Muhammad RaisRichmond$31K
- Zeeshan KhakwaniRichmond$8K
- Kimberly GeorgeRichmond$2K
- Thomas Platts MillsCharlottesville$176K
- Kelly MaplesNorfolk$26K
- Jaimin PatelHenrico$14K
- Sarah SprietFort Belvoir$9K
- Laura IspasLeesburg$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.